Spacelabs Healthcare launches Ultraview vital signs monitor
4 May 2010
Spacelabs Healthcare has launched the Ultraview DM3 dual-mode
vital signs monitor for adult and paediatric patients. It monitors SpO2,
pulse rate, non-invasive blood pressure, respiration and temperature.
The latest in the Ultraview series, the new DM3 can be used in
any patient care environment where basic vital signs monitoring is
needed. In Spot-Check mode, the DM3 supports batch collection of
basic vitals for multiple patients.
Supplemental patient information, such as pain level, patient
position (during NIBP), site check, and caregiver ID, can also be
specified by the user for inclusion in the patient’s record. After
collection of patient vitals has been completed, the DM3 can be
connected to the network to transmit the spot-check records for one
or multiple patients to the hospital’s EMR system.
In Monitoring mode, the DM3 provides continuous monitoring and
alarm support for patients who require more vigilance. In those
instances, such as following a procedure, short-term but constant
monitoring may be necessary based on variable patient acuity.
“In keeping with Spacelabs’ tradition of connecting innovation
with care, we are pleased to introduce the Ultraview DM3, a
versatile and cost-effective clinical solution, as well as an
exciting addition to our expanding line of monitoring and diagnostic
products,” said Group President Nicholas Ong.
The Ultraview DM3 has just recently received FDA 510(k) clearance
for market and sale within the United States. Plans are underway to
expand marketing and sales efforts into Canada, Europe, Middle East